Jump to navigation Jump to search
Ritodrine Wiki Str.png
Clinical data
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
Oral, parenteral
ATC code
Pharmacokinetic data
Protein binding~56%
Elimination half-life1.7-2.6 hours
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Molar mass287.354 g/mol
3D model (JSmol)

WikiDoc Resources for Ritodrine


Most recent articles on Ritodrine

Most cited articles on Ritodrine

Review articles on Ritodrine

Articles on Ritodrine in N Eng J Med, Lancet, BMJ


Powerpoint slides on Ritodrine

Images of Ritodrine

Photos of Ritodrine

Podcasts & MP3s on Ritodrine

Videos on Ritodrine

Evidence Based Medicine

Cochrane Collaboration on Ritodrine

Bandolier on Ritodrine

TRIP on Ritodrine

Clinical Trials

Ongoing Trials on Ritodrine at Clinical Trials.gov

Trial results on Ritodrine

Clinical Trials on Ritodrine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Ritodrine

NICE Guidance on Ritodrine


FDA on Ritodrine

CDC on Ritodrine


Books on Ritodrine


Ritodrine in the news

Be alerted to news on Ritodrine

News trends on Ritodrine


Blogs on Ritodrine


Definitions of Ritodrine

Patient Resources / Community

Patient resources on Ritodrine

Discussion groups on Ritodrine

Patient Handouts on Ritodrine

Directions to Hospitals Treating Ritodrine

Risk calculators and risk factors for Ritodrine

Healthcare Provider Resources

Symptoms of Ritodrine

Causes & Risk Factors for Ritodrine

Diagnostic studies for Ritodrine

Treatment of Ritodrine

Continuing Medical Education (CME)

CME Programs on Ritodrine


Ritodrine en Espanol

Ritodrine en Francais


Ritodrine in the Marketplace

Patents on Ritodrine

Experimental / Informatics

List of terms related to Ritodrine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Ritodrine (discontinued preparation: Yutopar) is a tocolytic drug, used to stop premature labor.[1] This drug has been removed from the US market, according to FDA Orange Book. It was available in oral tablets or as an injection and was typically used as the hydrochloride salt, ritodrine hydrochloride.


Ritodrine is a beta-2 adrenergic receptor agonist - a class of medication used for smooth muscle relaxation (other similar drugs are used in asthma or other pulmonary diseases such as salbutamol). Since ritodrine has a bulky N-substituent, it has high β2-selectivity. Also, the 4'-hydroxy on the benzene ring is important for activity as it is needed to form hydrogen bonds. However, the 4'-hydroxy makes it susceptible to metabolism by COMT. Since it is β2-selective it is used for premature labor.[2]

Side effects and potential contraindications

Most side effects of beta-2 agonists result from their concurrent beta-1 activity, and include increase in heart rate, rise in systolic pressure, decrease in diastolic pressure, chest pain secondary to MI, and arrhythmia. Beta agonists may also cause fluid retention secondary to decrease in water clearance, which when added to the tachycardia and increased myocardial work, may result in cardiac failure. In addition, they increase gluconeogenesis in the liver and muscle resulting in hyperglycemia, which increases insulin requirements in diabetic patients. The passage of beta-agonists through the placenta does occur and may be responsible for fetal tachycardia, as well as hypoglycemia or hyperglycemia at birth.

Patients with type 2 diabetes, high blood pressure or migraines should bring this to their doctor's attention before receiving care.

It has also been associated with post-partum hemorrhage.[citation needed]


  1. Li X, Zhang Y, Shi Z (February 2005). "Ritodrine in the treatment of preterm labour: a meta-analysis" (PDF). The Indian journal of medical research. 121 (2): 120–7. PMID 15756046.
  2. Medicinal Chemistry of Adrenergics and Cholinergics

Template:Other gynecologicals